1. (a) Unless otherwise authorized by law, a pharmacist shall only exercise the authority granted under paragraph (5) of the definition of "practice of pharmacy" in section 461-1 to order, perform, and report the results of certain CLIA-waived tests:

   1. (1) After completing appropriate training that includes programs approved by the Accreditation Council for Pharmacy Education, curriculum-based programs from an Accreditation Council for Pharmacy Education-accredited college of pharmacy, state or local health department programs, or programs recognized by the board, and any regulations promulgated by the federal Centers for Medicare and Medicaid Services; and
   2. (2) Upon application for and receipt of a permit pursuant to the requirements of section 321-13.
2. (b) Any pharmacist performing a CLIA-waived test for a patient shall report the results of the test to a minor patient's pediatrician or an adult patient's primary care provider, if such information is provided by the patient at the time of testing. The pharmacist shall attempt to solicit pediatrician or primary care provider information at the time of performing the CLIA-waived test.
3. (c) For any CLIA-waived tests performed, pharmacists shall follow all applicable state laws and rules regarding the reporting of diseases.

[L 2023, c 103, §2]